Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haupt Pharma Münster is a specialized contract development and manufacturing organization (CDMO) based in Germany and is a key operational site within the Aenova Group. The facility is recognized as a center of excellence for the production of high-potency compounds, specifically focusing on sex hormones and narcotics. Its service portfolio covers the entire pharmaceutical value chain, including formulation development, clinical trial supply, and large-scale commercial manufacturing and packaging. The site utilizes advanced containment technologies to ensure the safe handling of sensitive and potent active pharmaceutical ingredients. As part of a global CDMO network, the Münster location provides critical manufacturing services to an international client base in the pharmaceutical and biotech sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haupt Pharma Münster.